Free Access
Med Sci (Paris)
Volume 30, Number 3, Mars 2014
Page(s) 274 - 279
Section M/S Revues
Published online 31 March 2014
  1. LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001 ; 412 : 877–884. [CrossRef] [PubMed] [Google Scholar]
  2. Maldonado-Perez D, Evans J, Denison F, et al. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007 ; 18 : 66–72. [CrossRef] [PubMed] [Google Scholar]
  3. Bullock CM, Li JD, Zhou QY. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 2004 ; 65 : 582–588. [CrossRef] [PubMed] [Google Scholar]
  4. Lin R, LeCouter J, Kowalski J, Ferrara N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 2002 ; 277 : 8724–8729. [CrossRef] [PubMed] [Google Scholar]
  5. Soga T, Matsumoto S, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002 ; 1579 : 173–179. [CrossRef] [PubMed] [Google Scholar]
  6. Nebigil CG. Prokineticin receptors in cardiovascular function: foe or friend?. Trends Cardiovasc Med 2009 ; 19 : 55–60. [CrossRef] [PubMed] [Google Scholar]
  7. Brouillet S, Hoffmann P, Benharouga M, et al. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 2010 ; 21 : 2832–2843. [CrossRef] [PubMed] [Google Scholar]
  8. Brouillet S, Hoffmann P, Feige JJ, Alfaidy N. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab 2012 ; 23 : 501–508. [CrossRef] [PubMed] [Google Scholar]
  9. Matsumoto S, Yamazaki C, Masumoto KH, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 2006 ; 103 : 4140–4145. [CrossRef] [Google Scholar]
  10. Pitteloud N, Zhang C, Pignatelli D, et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2007 ; 104 : 17447–17452. [CrossRef] [Google Scholar]
  11. Dode C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2, prokineticin receptor-2. PLoS Genet 2006 ; 2 : e175. [CrossRef] [PubMed] [Google Scholar]
  12. Guimiot F, Teixeira L, Dode C, et al. Syndrome de Kallmann : une séquence fœtopathologique. Med Sci (Paris) 2011 ; 27 : 135–137. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. LeCouter J, Lin R, Tejada M, et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 2003 ; 100 : 2685–2690. [CrossRef] [Google Scholar]
  14. Samson M, Peale FV, Jr, Frantz G, et al. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 2004 ; 89 : 4078–4088. [CrossRef] [PubMed] [Google Scholar]
  15. Tu LH, Yu LL, Xiong CL, Zhang HP. Potential role of prokineticin 2 in experimental varicocele-induced rat testes. Urology 2012 ; 80 : 952 e15–9. [Google Scholar]
  16. Pasquali D, Rossi V, Staibano S, et al. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 2006 ; 147 : 4245–4251. [CrossRef] [PubMed] [Google Scholar]
  17. Ferrara N, LeCouter J, Lin R, Peale F. EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors. Biochim Biophys Acta 2004 ; 1654 : 69–78. [PubMed] [Google Scholar]
  18. Fraser HM, Bell J, Wilson H, et al. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 2005 ; 90 : 427–434. [CrossRef] [PubMed] [Google Scholar]
  19. Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006 ; 147 : 1675–1684. [CrossRef] [PubMed] [Google Scholar]
  20. Ferrara N, Frantz G, LeCouter J, et al. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 2003 ; 162 : 1881–1893. [CrossRef] [PubMed] [Google Scholar]
  21. Gao MZ, Zhao XM, Sun ZG, et al. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2011 ; 95 : 673–678. [CrossRef] [PubMed] [Google Scholar]
  22. Hoffmann P, Saoudi Y, Benharouga M, et al. Role of EG-VEGF in human placentation: Physiological and pathological implications. J Cell Mol Med 2009 ; 13 : 2224–2235. [CrossRef] [PubMed] [Google Scholar]
  23. Haouzi D, Mahmoud K, Fourar M, et al. Identification of new biomarkers of human endometrial receptivity in the natural cycle. Hum Reprod 2009 ; 24 : 198–205. [CrossRef] [PubMed] [Google Scholar]
  24. Shaw JL, Denison FC, Evans J, et al. Evidence of prokineticin dysregulation in fallopian tube from women with ectopic pregnancy. Fertil Steril 2010 ; 94 : 1601–1608 e1. [CrossRef] [PubMed] [Google Scholar]
  25. Su MT, Lin SH, Lee IW, et al. Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss. Hum Reprod 2010 ; 25 : 2923–2930. [CrossRef] [PubMed] [Google Scholar]
  26. Salker M, Teklenburg G, Molokhia M, et al. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions, causes recurrent pregnancy loss. PLoS One 2010 ; 5 : e10287. [CrossRef] [PubMed] [Google Scholar]
  27. Su MT, Lin SH, Chen YC, et al. Prokineticin receptor variants (PKR1–I379V and PKR2–V331M) are protective genotypes in human early pregnancy. Reproduction 2013 ; 146 : 63–73. [CrossRef] [PubMed] [Google Scholar]
  28. Brouillet S, Hoffmann P, Chauvet S, et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci 2012 ; 69 : 1537–1550. [CrossRef] [PubMed] [Google Scholar]
  29. Brouillet S, Murthi P, Hoffmann P, et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell Mol Life Sci 2013 ; 70 : 511–525. [CrossRef] [PubMed] [Google Scholar]
  30. Catalano RD, Lannagan TR, Gorowiec M, et al. Prokineticins: novel mediators of inflammatory and contractile pathways at parturition ?. Mol Hum Reprod 2010 ; 16 : 311–319. [CrossRef] [PubMed] [Google Scholar]
  31. Rigourd V, Chelbi ST, Vaiman D. La pré-éclampsie. Med Sci (Paris) 2008 ; 24 : 1017–1019. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.